FDA approves new ulcer drug (Daily Local News)
TREDYFFRIN A new Shire Pharmaceutical drug to treat ulcerative colitis is now available.

Fitch Rates Wyeth's New Sr. Unsecured Notes 'A-' (Business Wire via Yahoo! Finance)
CHICAGO----Fitch Ratings has assigned 'A-' rating to Wyeth's public issuance of $1.5 billion of 30-year senior unsecured notes. The Rating Outlook is Stable. Proceeds from the new senior unsecured debt are expected to be used for general corporate and working capital purposes.